Format

Send to

Choose Destination
Pharmacotherapy. 2013 Dec;33(12):1256-63. doi: 10.1002/phar.1327. Epub 2013 Jul 29.

Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.

Author information

1
Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan; Henry Ford Hospital, Detroit, Michigan.

Abstract

STUDY OBJECTIVES:

To describe the implementation of vancomycin dosing and monitoring practices recommended by the consensus guidelines in a diverse sample of hospitals, and to identify needs for quality improvement and research.

DESIGN:

Cross-sectional study using an online survey instrument.

SETTING:

Making a Difference in Infectious Diseases Pharmacotherapy (MAD-ID) Research Network.

PARTICIPANTS:

A total of 163 respondents from MAD-ID who work in antimicrobial stewardship and represent unique hospitals.

MEASUREMENTS AND MAIN RESULTS:

The survey population represented a wide range of patient populations (96% adult, 49% pediatric, and 23% long-term care) and settings (52% not-for-profit nonuniversity, 31% university based, and 11% for profit). Automatic consultation of pharmacy services for all vancomycin dosing was reported in 51% of the institutions. Among the dosing and monitoring practices endorsed by the consensus guidelines, participant institutions commonly followed these recommendations: use of trough concentrations without peak concentrations, maintenance of trough concentration higher than 10 mg/L, and target trough concentrations of 15-20 mg/L for complicated infections. In contrast, there was less consistent application of appropriate timing of trough concentrations, use of loading doses, and use of actual body weight. The remaining challenges and controversies surrounding vancomycin dosing are discussed.

CONCLUSION:

Despite the availability of consensus guideline recommendations, practices for dosing and monitoring of vancomycin are not universally applied. The findings of this survey highlight many opportunities for future research and quality improvement strategies.

KEYWORDS:

Vancomycin; clinical pharmacy services; survey; therapeutic drug monitoring

PMID:
23897602
DOI:
10.1002/phar.1327
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center